GSA Capital Partners’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
+73,296
| New | +$281K | 0.02% | 1297 |
|
|
2024
Q3 | – | Sell |
-16,020
| Closed | -$53K | – | 1562 |
|
|
2024
Q2 | $53K | Sell |
16,020
-9,229
| -37% | -$30.5K | ﹤0.01% | 1563 |
|
|
2024
Q1 | $83K | Sell |
25,249
-143,514
| -85% | -$472K | 0.01% | 1504 |
|
|
2023
Q4 | $592K | Buy |
168,763
+153,499
| +1,006% | +$538K | 0.05% | 684 |
|
|
2023
Q3 | $102K | Sell |
15,264
-64,443
| -81% | -$431K | 0.01% | 1384 |
|
|
2023
Q2 | $669K | Sell |
79,707
-13,237
| -14% | -$111K | 0.07% | 553 |
|
|
2023
Q1 | $923K | Sell |
92,944
-50,264
| -35% | -$499K | 0.09% | 357 |
|
|
2022
Q4 | $997K | Buy |
143,208
+39,360
| +38% | +$274K | 0.12% | 208 |
|
|
2022
Q3 | $555K | Buy |
+103,848
| New | +$555K | 0.07% | 490 |
|
|
2022
Q2 | – | Sell |
-59,934
| Closed | -$266K | – | 1361 |
|
|
2022
Q1 | $266K | Sell |
59,934
-66,180
| -52% | -$294K | 0.04% | 980 |
|
|
2021
Q4 | $504K | Buy |
126,114
+22,838
| +22% | +$91.3K | 0.06% | 592 |
|
|
2021
Q3 | $907K | Buy |
103,276
+80,407
| +352% | +$706K | 0.09% | 356 |
|
|
2021
Q2 | $259K | Buy |
+22,869
| New | +$259K | 0.03% | 1035 |
|
|
2021
Q1 | – | Sell |
-61,220
| Closed | -$420K | – | 1068 |
|
|
2020
Q4 | $420K | Buy |
61,220
+35,717
| +140% | +$245K | 0.07% | 535 |
|
|
2020
Q3 | $189K | Buy |
+25,503
| New | +$189K | 0.03% | 1021 |
|